Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Xavier Poiré"'
Autor:
Edgar Faber, Aida Botelho de Sousa, Ibrahim Yakoub-Agha, Irma Khvedelidze, Xavier Poiré, Ariane Boumendil, Joanna Romejko-Jarosinska, Anna Sureda, Herve Finel, Hervé Ghesquières, Kazimierz Hałaburda, Achilles Anagnostopoulos, Saad Akhtar, Carmen Martínez, Silvia Montoto, Vincenzo Pavone, Gunhan Gurman
Publikováno v:
Leukemia & Lymphoma. 61:2915-2922
The purpose of this study was to analyze the results of second autologous hematopoietic stem cell transplantation (ASCT2) for patients with relapsed/refractory Hodgkin lymphoma (HL) after a first transplantation (ASCT1). Outcomes for 56 patients rece
Autor:
Thomas F. Gajewski, Kathy Conner, Todd M. Zimmerman, Koen van Besien, Carolyn Muhs, Justin Kline, Xavier Poiré, David L. Grinblatt, Sonali M. Smith
Publikováno v:
Leukemia & Lymphoma. 51:1241-1250
High-dose chemotherapy followed by autologous stem cell transplant (ASCT) leads to durable remissions in approximately half of patients with chemosensitive relapsed or refractory aggressive lymphomas; however, many will relapse despite ASCT secondary
Autor:
Olatoyosi Odenike, Justin Kline, Elizabeth Rich, Xavier Poiré, Wendy Stock, Koen van Besien, Lucy A. Godley, Richard A. Larson, Andrew S. Artz
Publikováno v:
Leukemia & Lymphoma. 50:85-91
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the treatment of choice for patients with chronic myelogenous leukemia (CML) who have failed or are intolerant to tyrosine kinase inhibitors (TKI). Myeloablative conditioning regimens